Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of cancer therapies and a remarkable potential upside..
MBX Biosciences, Inc. (MBX) is making waves in the biotechnology sector with its focus on precision peptide therapies aimed at treating endocrine and metabolic disorders. With a market cap of..
Septerna, Inc. (SEPN), a burgeoning name in the biotechnology sector, has captured investor attention with its remarkable revenue growth and potential upside. As a clinical-stage biotech company, Septerna is pioneering..
Abivax SA (ABVX), a French biotechnology powerhouse, is drawing significant investor attention with its promising potential upside of 22.77% as indicated by analyst targets. Operating at the cutting edge of..
As a relatively new entrant in the healthcare sector, Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology industry. Incorporated in 2023 and headquartered in Durham, North Carolina,..
For investors with an eye on the healthcare sector, AtaiBeckley Inc. (NASDAQ: ATAI) offers a compelling case of innovation in mental health treatment, coupled with a striking potential upside of..
PureTech Health plc (PRTC), a biotechnology firm based in Boston, Massachusetts, is quietly making waves in the healthcare sector. With a focus on developing and commercializing innovative biotech and pharmaceutical..
Neuropace, Inc. (NASDAQ: NPCE), a pioneering player in the healthcare sector, is drawing significant attention from investors. With its focus on medical devices, specifically targeting drug-resistant focal epilepsy through its..
Xencor, Inc. (NASDAQ: XNCR) is capturing the attention of investors in the healthcare sector, particularly those interested in biotechnology. The company, based in Pasadena, California, is a clinical-stage biopharmaceutical entity..
Rapport Therapeutics, Inc. (NASDAQ: RAPP) is generating significant buzz in the biotechnology sector with its promising pipeline of treatments for central nervous system (CNS) disorders. As a clinical-stage biopharmaceutical company,..
Autolus Therapeutics plc (NASDAQ: AUTL), a prominent player in the biotechnology sector, is capturing investor attention with its innovative T cell therapies aimed at treating cancer and autoimmune diseases. Headquartered..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, has recently captured investor attention due to its promising potential upside of 23.71%. With a market capitalization of $1.54 billion, AnaptysBio operates..
Sonida Senior Living, Inc. (NYSE: SNDA), a prominent player in the healthcare sector, specializes in providing senior housing and a broad array of care services across the United States. With..
Standard BioTools Inc. (NASDAQ: LAB), a prominent player in the medical devices sector, presents an intriguing opportunity for investors with its considerable potential upside of 39.64%. Known for its innovative..
Celcuity Inc. (NASDAQ: CELC) is emerging as a compelling player in the biotechnology sector, especially for investors seeking exposure to innovative, clinical-stage companies focused on cancer therapies. With a market..
